Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-27
2008-05-27
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S255010, C514S248000, C514S249000, C514S250000, C544S360000, C544S386000
Reexamination Certificate
active
11215064
ABSTRACT:
Derivatives of urea that contain piperazine rings and additional substitution with aromatic groups are effective in ameliorating conditions associated with unwanted calcium ion channel activity.
REFERENCES:
patent: 5428038 (1995-06-01), Chatterjee et al.
patent: 5646149 (1997-07-01), Hellberg et al.
patent: 5703071 (1997-12-01), Itoh et al.
patent: 6011035 (2000-01-01), Snutch et al.
patent: 6294533 (2001-09-01), Snutch et al.
patent: 6310059 (2001-10-01), Snutch
patent: 6458781 (2002-10-01), Connor et al.
patent: 6492375 (2002-12-01), Snutch
patent: 6943168 (2005-09-01), Snutch et al.
patent: 6949554 (2005-09-01), Snutch et al.
patent: 6951862 (2005-10-01), Snutch et al.
patent: 2002/0019389 (2002-02-01), Kim
patent: 2004/0034035 (2004-02-01), Snutch et al.
patent: 2004/0044004 (2004-03-01), Snutch et al.
patent: 2004/0147529 (2004-07-01), Snutch et al.
patent: 2004/0192703 (2004-09-01), Snutch et al.
patent: 2004/0259866 (2004-12-01), Snutch et al.
patent: 2004/0266784 (2004-12-01), Snutch et al.
patent: 2006/0084660 (2006-04-01), Snutch et al.
patent: 2 335 461 (2000-01-01), None
patent: 0 441 226 (1991-08-01), None
patent: WO-97/24325 (1997-07-01), None
patent: WO-00/01375 (2000-01-01), None
patent: WO-01/45709 (2001-06-01), None
patent: WO-01/46166 (2001-06-01), None
patent: WO-01/49670 (2001-07-01), None
patent: WO-01/95856 (2001-12-01), None
patent: WO01085856 (2001-12-01), None
patent: WO-2004/089377 (2004-10-01), None
patent: WO-2004/089922 (2004-10-01), None
LaVoie and Patani. Chemical Reviews, 1996, 96, 3147-3176.
Augustine et al., Annu. Rev. Neurosci. (1987) 10:633-692.
Backonja et al., JAMA (1998) 280:1831-1836.
Bowersox et al., J. Pharmacol. Exp. Ther. (1996) 279:1243-1249.
Caraceni et al., J. Pain & Symp. Manag. (1999) 17:441-445.
Catterall, Annu. Rev. Cell Dev. Biol. (2000) 16:521-555.
Cesena, Neuro. Sci. Lett. (1999) 262:101-104.
Cheng et al., Anesthesiology (2000) 92:1126-1131.
Di Trapani et al., Clin. Ter. (2000) 151:145-148.
Dogrul et al., Pain (2003) 105:159-168.
Dooley, Current Opinion in CPNS Investigational Drugs (1999) 1:116-125.
Field et al., Pain (1999) 80:391-398.
Gomora et al., Mol. Pharmacol. (2001) 60:1121-1132.
Gould et al., PNAS USA (1983) 80:5122-5125.
Grantham et al., Brit. J. Pharmacol. (1944) 111:483-488.
Hatakeyama et al., Neuro Report (2001) 12:2423-2427.
Heading, Curr. Opin. CPNS Investigational Drugs (1999) 1:153-166.
Heady et al., Jpn. J. Pharmacol. (2001) 85:339-350.
Houtchens et al., Multiple Sclerosis (1997) 3:250-253.
Huguenard, Annu. Rev. Physiol. (1996) 58:329-348.
Ino et al., PNAS USA (2001) 98:5323-5328.
International Search Report for PCT/CA2005/001324, mailed on Dec. 14, 2005, 6 pages.
Kim et al., Mol. Cell Neurosci. (2001) 18:235-245.
Kim et al., Neuron (2001) 31:35-45.
King et al., J. Biol. Chem. (1989) 264:5633-5641.
Laird et al., Annal. Pharmacotherap. (2000) 34:802-807.
Magnus, Epilepsia (1999) 40:S66-S72.
Malmberg et al., J. Neurosci. (1994) 14:4882-4890.
Mathur, Seminars in Anesthesia, Perioperative Medicine and Pain (2000) 19:67-75.
Miller, Science (1987) 235:46-52.
Nicholson, Acta. Neurol. Scand. (2000) 101:359-371.
Ridgeway et al., Pain (2000) 85:287-289.
Rowbotham et al., JAMA (1998) 280:1837-1842.
Saegusa et al., PNAS USA (2001) 97:6132-6137.
Sluka, J. Pharmacol. Exp. Ther. (1998) 287:232-237.
Stea et al., Handbook on Ion Channels, R.A. North (ed.), CRC Press, (1994) pp. 113-151.
Stea et al., PNAS USA (1994) 91:10576-10580.
Su et al., J. Neurosci. (2002) 22:3645-3655.
Taylor et al., Epilepsy Res. (1998) 29:233-249.
Vanegas et al., Pain (2000) 85:9-18.
Wang et al., Soc. Neurosci. Abstr. (1998) 24:1626.
Ding Yanbing
Pajouhesh Hassan
Pajouhesh Hossein
Snutch Terrance P.
Jarrell Noble
Morrison & Foerster / LLP
Neuromed Pharmaceuticals Ltd.
Wilson James O.
LandOfFree
Urea derivatives as calcium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urea derivatives as calcium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urea derivatives as calcium channel blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3919538